Dermatomyositis
- PMID: 10615903
- DOI: 10.1016/S0140-6736(99)05157-0
Dermatomyositis
Abstract
Dermatomyositis is one of the idiopathic inflammatory myopathies with characteristic cutaneous manifestations including the heliotrope rash, Gottron's papules, cuticular changes including periungual telangiectasia, a photodistributed erythema or poikiloderma, and a scaly alopecia. Dermatomyositis has been linked to cancer, particularly ovarian cancer. Cancer-associated disease is more commonly found in older patients, and when present, is associated with a poor prognosis. A childhood form of the disease exists and is frequently complicated by the development of calcinosis. Dermatomyositis is a systemic disorder and whereas the skin and muscles are the most commonly affected organs, patients may have arthralgias, arthritis, oesophageal disease, or cardiopulmonary dysfunction. Recently described serological abnormalities, known as myositis-specific antibodies, add credence to the notion that this disorder is distinct from all other collagen-vascular diseases, and may lead to important discoveries about the pathogenesis of the inflammatory myopathies, which are not currently of practical use in the clinic or office. Management of the patient with myositis usually includes systemic corticosteroids with or without an immunosuppressive agent. Cutaneous disease is more difficult to manage, but antimalarials, methotrexate, and intravenous immunoglobulin are effective in small, often open-label, studies.
Comment in
-
Heterogeneity of juvenile dermatomyositis.Lancet. 2000 Apr 1;355(9210):1186. doi: 10.1016/S0140-6736(05)72266-2. Lancet. 2000. PMID: 10791405 No abstract available.
Similar articles
-
[Dermatomyositis and polymyositis: clinical aspects and treatment].Ann Med Interne (Paris). 2001 Nov;152(7):455-64. Ann Med Interne (Paris). 2001. PMID: 11965087 French.
-
[Myositis and the skin: cutaneous manifestations of dermatomyositis].Brain Nerve. 2013 Nov;65(11):1283-90. Brain Nerve. 2013. PMID: 24200606 Review. Japanese.
-
[Polymyositis/dermatomyositis--clinical picture and treatment].Reumatizam. 2012;59(2):44-50. Reumatizam. 2012. PMID: 23745455 Croatian.
-
Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report.J Med Case Rep. 2018 Mar 24;12(1):83. doi: 10.1186/s13256-018-1618-y. J Med Case Rep. 2018. PMID: 29571300 Free PMC article.
-
An overview of polymyositis and dermatomyositis.Muscle Nerve. 2015 May;51(5):638-56. doi: 10.1002/mus.24566. Muscle Nerve. 2015. PMID: 25641317 Review.
Cited by
-
[Dermatomyositis-update].Hautarzt. 2015 Aug;66(8):604-10. doi: 10.1007/s00105-015-3659-0. Hautarzt. 2015. PMID: 26219226 Review. German.
-
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum.Cureus. 2022 Mar 8;14(3):e22978. doi: 10.7759/cureus.22978. eCollection 2022 Mar. Cureus. 2022. PMID: 35415038 Free PMC article. Review.
-
Identification of 6 dermatomyositis subgroups using principal component analysis-based cluster analysis.Int J Rheum Dis. 2019 Aug;22(8):1383-1392. doi: 10.1111/1756-185X.13609. Epub 2019 Jun 9. Int J Rheum Dis. 2019. PMID: 31179648 Free PMC article.
-
Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis.Pediatr Rheumatol Online J. 2023 Sep 19;21(1):104. doi: 10.1186/s12969-023-00894-9. Pediatr Rheumatol Online J. 2023. PMID: 37726751 Free PMC article.
-
Breast calcinosis in a patient with Dermatomyositis.Eur J Rheumatol. 2017 Jun;4(2):175-176. doi: 10.5152/eurjrheum.2016.15080. Epub 2016 Apr 5. Eur J Rheumatol. 2017. PMID: 28638697 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical